October 25, 2017

SNMMI Publishes Appropriate Use Criteria for FDG PET/CT in Restaging and Treatment Response Assessment of Malignant Disease

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has published appropriate use criteria (AUC) for FDG PET/CT in restaging and treatment response assessment of malignant disease. As cancer patients move through therapy, FDG PET/CT has proven an effective tool for assessing treatment response and updating the stage of malignancy. This AUC aims to improve utilization and guide providers across specialties in its use. (read more here)